Tag: corticosteroids market insights

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Corticosteroids Market Poised To Hit $8.33 Billion By 2030 With A 7.1% CAGR

The corticosteroids market has experienced significant expansion in recent years. It is projected to increase from $5.93 billion in 2025 to $6.33 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. This historic growth is attributable to factors such as the increasing occurrence of asthma and allergies, the confirmed clinical effectiveness of corticosteroids, extensive implementation of steroid treatments by hospitals, enhanced understanding of inflammatory disease management, and a growth in pharmaceutical production capabilities.

The corticosteroids market size is anticipated to expand significantly in the coming years, with projections indicating it will reach $8.34 billion by 2030, progressing at a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is propelled by factors such as the increasing burden of autoimmune and respiratory diseases, the development of safer steroid formulations, a globally aging population, enhanced healthcare access in emerging economies, and greater investment in corticosteroid research. Key trends expected over the forecast period include the advent of targeted corticosteroid formulations, therapies employing low doses and short durations, a rise in the use of topical and inhaled corticosteroids, combination therapies with bronchodilators, and an expanded application in acute respiratory care.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=17092912&type=smp&name=Corticosteroids%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Corticosteroids Market Growth Catalysts And Demand Drivers

The increasing need for cancer treatment is projected to boost the corticosteroid market. Cancer treatment involves diverse therapies like surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments, all aimed at eliminating cancer cells and relieving symptoms. This escalating demand for cancer treatment is fueled by several factors, including a rise in cancer incidence, improved awareness and screening efforts, enhanced access to healthcare, and the availability of supportive care services. Corticosteroids play a vital role by mitigating symptoms and improving the tolerability of cancer therapies, which leads to better patient outcomes and supports the expanding requirement for holistic cancer care. An illustrative example comes from May 2024, when the UK’s healthcare system, the National Health Service (NHS), reported record-high treatment activity, with more than 1,400 patients starting cancer treatment every working day. Furthermore, approximately 340,000 individuals received their first cancer treatment between April 2023 and March 2024. Ultimately, the growing demand for cancer treatment is a key driver for the corticosteroid market’s expansion.

Corticosteroids Market Segment Analysis Spotlighting Growth Areas

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

Corticosteroids Market Trends Shaping Long-Term Demand

Major companies operating in the corticosteroids market are developing innovative products like rescue medications to cater to larger customer bases, boost sales, and increase revenue. Rescue medication refers to a type of treatment or drug employed to provide quick and immediate relief from acute and severe symptoms of a medical condition or a sudden worsening of a chronic ailment. For instance, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced the FDA approval for Airsupra (albuterol/budesonide). A distinctive characteristic of this product is its role as the first-in-class pressurized metered-dose inhaler (pMDI), a fixed-dose combination rescue medication. It contains albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) with anti-inflammatory properties. This product is indicated for individuals aged 18 years and older and can be utilized on an as-needed basis for the treatment or prevention of bronchoconstriction. It also assists in lowering the risk of asthma exacerbations. This combination is available in the United States and is under development by AstraZeneca in collaboration with Avillion.

Corticosteroids Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

View The Full Corticosteroids Market Report:

https://thebusinessresearchcompany.com/report/Corticosteroid-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Corticosteroids Market Regional Analysis And Leading Geography

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Corticosteroids Market Forecast: What Market Value Is Expected By 2030?

The corticosteroids market has experienced robust expansion in recent years, with projections indicating an increase from $5.93 billion in 2025 to $6.33 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.7%. This past growth has been driven by several key factors, including the growing incidence of asthma and allergic conditions, the well-documented therapeutic effectiveness of corticosteroids, their extensive use in hospital settings for steroid-based treatments, heightened awareness surrounding the management of inflammatory diseases, and a broadening of pharmaceutical production capabilities.

The corticosteroids market is projected to experience significant growth over the coming years. By 2030, the market value is anticipated to reach $8.34 billion, expanding at a compound annual growth rate (CAGR) of 7.1%. Several factors are set to fuel this expansion during the forecast period, including the rising prevalence of autoimmune and respiratory conditions, the creation of safer steroid products, an increasingly elderly global population, improved healthcare availability in developing nations, and heightened funding for corticosteroid research. Among the key developments shaping this period are the emergence of targeted corticosteroid preparations, adoption of low-dose and short-duration treatment regimens, increased usage of topical and inhaled steroids, bronchodilator combination therapies, and growing application in acute respiratory care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Corticosteroids Market Growth Drivers: What Factors Are Accelerating Expansion?

The corticosteroid market is expected to expand in the coming years, driven by the growing need for cancer therapies. Cancer treatment includes a range of approaches like surgery, chemotherapy, radiation, immunotherapy, and targeted therapies, all aimed at destroying cancer cells and reducing symptoms. This rising demand is fueled by factors such as higher cancer rates, increased awareness and screening, better healthcare access, and the availability of supportive care services. Corticosteroids improve patient outcomes by easing symptoms and making cancer treatments more tolerable, which in turn supports the growing need for comprehensive cancer care. For example, in May 2024, the UK’s National Health Service (NHS) reported that treatment activity hit an all-time high, with over 1,400 patients starting cancer treatment each working day. From April 2023 to March 2024, nearly 340,000 people received their first cancer treatment. Thus, the increasing demand for cancer treatment is driving growth in the corticosteroid market.

Corticosteroids Market Segmentation Trends And Revenue Drivers

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

Corticosteroids Market Trends: What Is Shaping Future Industry Growth?

Major players within the corticosteroids industry are focusing on creating advanced solutions like rescue medications to serve a broader audience, boost sales, and enhance revenue streams. Rescue medication is defined as a treatment administered to deliver fast and immediate relief from acute, severe symptoms or a sudden worsening of a chronic condition. As an example, in January 2023, the UK-based pharmaceutical firm AstraZeneca PLC obtained FDA clearance for Airsupra (albuterol/budesonide). A notable feature of this product is that it represents the first pressurized metered-dose inhaler (pMDI) of its kind, functioning as a fixed-dose combination rescue medication. It combines albuterol, a short-acting beta2-agonist (SABA), with budesonide, an inhaled corticosteroid (ICS) that possesses anti-inflammatory properties. This medication is approved for use in individuals who are 18 years and older and may be taken as needed to address or prevent bronchoconstriction. Additionally, it aids in decreasing the likelihood of asthma attacks. This combination is currently accessible in the United States and is being advanced by AstraZeneca in partnership with Avillion.

Corticosteroids Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Access The Complete Corticosteroids Market Report:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Corticosteroids Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The Corticosteroids Market Become By 2030 Compared To 2026?

The corticosteroids market has observed significant growth in recent years. Its valuation is anticipated to increase from $5.93 billion in 2025 to $6.33 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. This historical expansion can be attributed to factors such as the increasing prevalence of asthma and allergies, the proven clinical effectiveness of corticosteroids, widespread implementation of steroid therapies in hospitals, enhanced awareness of inflammatory disease management, and the growth in pharmaceutical manufacturing capabilities.

The corticosteroids market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $8.34 billion, growing at a compound annual growth rate (CAGR) of 7.1%. This projected growth is driven by several factors, including an increasing prevalence of autoimmune and respiratory diseases, the creation of safer steroid products, an expanding global elderly population, improved healthcare accessibility in developing nations, and enhanced funding for corticosteroid studies. Key developments expected during this period encompass the introduction of targeted corticosteroid products, therapies involving lower doses and shorter durations, an increase in topical and inhaled corticosteroid use, combination treatments with bronchodilators, and broader application in emergency respiratory care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

What Major Growth Factors Are Impacting The Corticosteroids Market?

The expanding need for cancer therapies is set to drive the growth of the corticosteroid market in the future. Cancer treatment involves diverse approaches like surgery, chemotherapy, radiation, immunotherapy, and targeted therapies, all aimed at eliminating cancer cells and mitigating symptoms. This increasing demand for cancer care stems from factors such as a higher incidence of cancer, enhanced public awareness and screening programs, better access to healthcare services, and the provision of supportive care. Corticosteroids contribute to better patient outcomes by easing symptoms and making cancer treatments more tolerable, which in turn reinforces the growing need for extensive cancer care. For example, in May 2024, the National Health Service (NHS), the UK’s healthcare system, reported record-high treatment activity, with more than 1,400 patients starting cancer treatment daily. Additionally, between April 2023 and March 2024, close to 340,000 individuals began their initial cancer treatment. Consequently, the escalating demand for cancer treatment fuels the expansion of the corticosteroid market.

What Are The Core Segment Classifications In The Corticosteroids Market?

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

Which Trends Are Shaping The Corticosteroids Market Landscape?

Leading companies in the corticosteroids market are developing innovative products like rescue medications to cater to larger customer bases, boost sales, and increase revenue. A rescue medication refers to a type of treatment or drug that provides quick, immediate relief from severe and acute symptoms of a medical condition or a sudden worsening of a chronic condition. For instance, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced the FDA approval for Airsupra (albuterol/budesonide). A distinctive characteristic of this product is its classification as the first-in-class pressurized metered-dose inhaler (pMDI), which is a fixed-dose combination rescue medication. It contains albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) with anti-inflammatory properties. This product is indicated for individuals aged 18 years and older and can be used on an as-needed basis for the treatment or prevention of bronchoconstriction. It also assists in lowering the risk of asthma exacerbations. This combination is available in the United States and is currently under development by AstraZeneca in collaboration with Avillion.

Who Are The Prominent Players Across The Corticosteroids Market?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Access The Complete Corticosteroids Market Report:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Which Region Accounts For The Highest Share Of The Corticosteroids Market?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Corticosteroids Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company

Drugs For Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Corticosteroids Market Between 2026 And 2030?

The corticosteroids market has experienced significant growth in recent years. It is anticipated to increase from $5.93 billion in 2025 to $6.33 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. This historic expansion can be attributed to the rising prevalence of asthma and allergies, the established clinical efficacy of corticosteroids, the widespread hospital adoption of steroid therapies, increased awareness regarding inflammatory disease management, and the expansion of pharmaceutical manufacturing capacity.

The corticosteroids market is projected to experience substantial expansion in the coming years, with its valuation set to reach $8.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This anticipated growth during the forecast period stems from several factors, including the increasing prevalence of autoimmune and respiratory diseases, advancements in developing safer steroid formulations, the worldwide aging demographic, improved healthcare accessibility in developing nations, and enhanced funding for corticosteroid research. Key developments expected within this period encompass the emergence of targeted corticosteroid formulations, therapies involving lower doses and shorter durations, an increase in the adoption of topical and inhaled corticosteroids, combination treatments with bronchodilators, and the expanded application in acute respiratory care settings.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

What Leading Drivers Are Supporting The Corticosteroids Market Expansion?

The escalating need for cancer treatment is expected to boost the growth of the corticosteroid market in the coming years. Cancer treatment comprises various therapeutic approaches, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted interventions, all aimed at eliminating cancer cells and alleviating associated symptoms. The heightened demand for cancer treatment arises from several contributors, such as a growing incidence of cancer, increased public awareness and screening efforts, enhanced access to healthcare facilities, and the provision of supportive care services. Corticosteroids play a role in improving patient outcomes by easing symptoms and making cancer treatments more tolerable, thereby underpinning the increasing necessity for comprehensive cancer care. For example, in May 2024, the National Health Service (NHS), the UK’s healthcare system, reported that treatment activity reached an all-time high, with over 1,400 patients commencing cancer treatment every working day. Between April 2023 and March 2024, nearly 340,000 individuals received their first cancer treatment. Hence, the rising demand for cancer treatment fuels the expansion of the corticosteroid market.

How Are Segments Identified Within The Corticosteroids Market Segment Framework?

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

What Trends Are Affecting The Growth Of The Corticosteroids Market?

Leading firms within the corticosteroids market are creating advanced products, including rescue medications, with the aim of attracting a broader customer base, boosting sales, and enhancing revenue. Rescue medications are defined as treatments or drugs designed to offer rapid and immediate alleviation of acute, severe symptoms of a health condition or sudden worsening of a long-term illness. For example, in January 2023, UK-based pharmaceutical company AstraZeneca PLC disclosed the FDA’s approval for Airsupra (albuterol/budesonide). A key feature of this product is its status as the first-in-class pressurized metered-dose inhaler (pMDI), serving as a fixed-dose combination rescue medication. It combines albuterol, a short-acting beta2-agonist (SABA), with budesonide, an inhaled corticosteroid (ICS) known for its anti-inflammatory effects. This product is prescribed for individuals 18 years and older and can be used as required to treat or prevent bronchoconstriction. Additionally, it contributes to reducing the likelihood of asthma exacerbations. This formulation is accessible in the United States and is being developed by AstraZeneca in partnership with Avillion.

Who Are The Companies Competing Within The Corticosteroids Market?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Get The Full Corticosteroids Market Report:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Which Region Leads The Corticosteroids Market In Overall Market Size?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Corticosteroids Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company

Drugs For Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Corticosteroids Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The corticosteroids market has demonstrated substantial growth in recent years. This market is projected to expand from $5.93 billion in 2025 to reach $6.33 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.7%. Its historical expansion can be attributed to factors such as the increasing prevalence of asthma and allergies, the established clinical efficacy of corticosteroids, the widespread adoption of steroid therapies within hospitals, enhanced awareness of inflammatory disease management, and the expansion of pharmaceutical manufacturing capacity.

The corticosteroids market is anticipated to show considerable growth in the upcoming years. It is forecast to expand to $8.34 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This expected increase can be attributed to several factors including the rising burden of autoimmune and respiratory diseases, the development of more secure steroid formulations, the global aging population, improved healthcare accessibility in emerging economies, and increased funding for corticosteroid research. Notable trends during the forecast period are targeted corticosteroid formulations, low-dose and short-duration treatments, a surge in topical and inhaled corticosteroids, combination therapies with bronchodilators, and their expanding application in acute respiratory care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

What Key Drivers Are Influencing The Growth Of The Corticosteroids Market?

The expanding need for cancer therapies is set to drive the growth of the corticosteroid market in the future. Cancer treatment involves a range of approaches, including surgical procedures, chemotherapy, radiation therapy, immunotherapy, and specific targeted interventions, all aimed at eliminating cancerous cells and mitigating symptoms. This growing demand for cancer care stems from multiple factors, such as a higher occurrence of cancer cases, enhanced public awareness and screening efforts, better availability of healthcare, and the provision of supportive care options. Corticosteroids play a crucial role by easing symptoms and improving the tolerance of cancer treatments, which in turn leads to better results for patients and reinforces the rising need for holistic cancer management. As an illustration, in May 2024, the UK’s National Health Service (NHS) indicated that treatment levels reached an unprecedented peak, with more than 1,400 patients starting cancer treatment daily on working days. From April 2023 to March 2024, approximately 340,000 individuals received their initial cancer treatment. Consequently, the increased requirement for cancer treatment propels the expansion of the corticosteroid market.

What Major Segment Divisions Exist Within The Corticosteroids Market?

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

How Are Trends Shaping The Direction Of The Corticosteroids Market?

Leading companies within the corticosteroids market are engaged in developing innovative products, such as rescue medications, to cater to broader customer bases, achieve greater sales, and boost revenue. A rescue medication refers to a type of treatment or drug administered for swift and immediate relief from acute and severe symptoms of a medical condition or a sudden worsening of a chronic ailment. As an illustration, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced the FDA approval for Airsupra (albuterol/budesonide). A distinguishing feature of this product is its designation as the first-in-class pressurized metered-dose inhaler (pMDI), functioning as a fixed-dose combination rescue medication. It incorporates albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) endowed with anti-inflammatory characteristics. This product is indicated for individuals aged 18 years and above and can be employed as needed for addressing or preventing bronchoconstriction. It also assists in decreasing the risk of asthma exacerbations. This combination is accessible in the United States and is under development by AstraZeneca in collaboration with Avillion.

Which Companies Are Leading Innovation In The Corticosteroids Market?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Read the full corticosteroids market report here:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Corticosteroids Market?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Corticosteroids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2832&type=smp

Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company

Drugs For Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Corticosteroids Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The corticosteroids market has demonstrated substantial growth in recent years. This market is projected to expand from $5.93 billion in 2025 to reach $6.33 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.7%. Its historical expansion can be attributed to factors such as the increasing prevalence of asthma and allergies, the established clinical efficacy of corticosteroids, the widespread adoption of steroid therapies within hospitals, enhanced awareness of inflammatory disease management, and the expansion of pharmaceutical manufacturing capacity.

The corticosteroids market is anticipated to show considerable growth in the upcoming years. It is forecast to expand to $8.34 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This expected increase can be attributed to several factors including the rising burden of autoimmune and respiratory diseases, the development of more secure steroid formulations, the global aging population, improved healthcare accessibility in emerging economies, and increased funding for corticosteroid research. Notable trends during the forecast period are targeted corticosteroid formulations, low-dose and short-duration treatments, a surge in topical and inhaled corticosteroids, combination therapies with bronchodilators, and their expanding application in acute respiratory care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

What Key Drivers Are Influencing The Growth Of The Corticosteroids Market?

The expanding need for cancer therapies is set to drive the growth of the corticosteroid market in the future. Cancer treatment involves a range of approaches, including surgical procedures, chemotherapy, radiation therapy, immunotherapy, and specific targeted interventions, all aimed at eliminating cancerous cells and mitigating symptoms. This growing demand for cancer care stems from multiple factors, such as a higher occurrence of cancer cases, enhanced public awareness and screening efforts, better availability of healthcare, and the provision of supportive care options. Corticosteroids play a crucial role by easing symptoms and improving the tolerance of cancer treatments, which in turn leads to better results for patients and reinforces the rising need for holistic cancer management. As an illustration, in May 2024, the UK’s National Health Service (NHS) indicated that treatment levels reached an unprecedented peak, with more than 1,400 patients starting cancer treatment daily on working days. From April 2023 to March 2024, approximately 340,000 individuals received their initial cancer treatment. Consequently, the increased requirement for cancer treatment propels the expansion of the corticosteroid market.

What Major Segment Divisions Exist Within The Corticosteroids Market?

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

How Are Trends Shaping The Direction Of The Corticosteroids Market?

Leading companies within the corticosteroids market are engaged in developing innovative products, such as rescue medications, to cater to broader customer bases, achieve greater sales, and boost revenue. A rescue medication refers to a type of treatment or drug administered for swift and immediate relief from acute and severe symptoms of a medical condition or a sudden worsening of a chronic ailment. As an illustration, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced the FDA approval for Airsupra (albuterol/budesonide). A distinguishing feature of this product is its designation as the first-in-class pressurized metered-dose inhaler (pMDI), functioning as a fixed-dose combination rescue medication. It incorporates albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) endowed with anti-inflammatory characteristics. This product is indicated for individuals aged 18 years and above and can be employed as needed for addressing or preventing bronchoconstriction. It also assists in decreasing the risk of asthma exacerbations. This combination is accessible in the United States and is under development by AstraZeneca in collaboration with Avillion.

Which Companies Are Leading Innovation In The Corticosteroids Market?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Read the full corticosteroids market report here:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Corticosteroids Market?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Corticosteroids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2832&type=smp

Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company

Drugs For Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Corticosteroids Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The corticosteroids market has demonstrated substantial growth in recent years. This market is projected to expand from $5.93 billion in 2025 to reach $6.33 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.7%. Its historical expansion can be attributed to factors such as the increasing prevalence of asthma and allergies, the established clinical efficacy of corticosteroids, the widespread adoption of steroid therapies within hospitals, enhanced awareness of inflammatory disease management, and the expansion of pharmaceutical manufacturing capacity.

The corticosteroids market is anticipated to show considerable growth in the upcoming years. It is forecast to expand to $8.34 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This expected increase can be attributed to several factors including the rising burden of autoimmune and respiratory diseases, the development of more secure steroid formulations, the global aging population, improved healthcare accessibility in emerging economies, and increased funding for corticosteroid research. Notable trends during the forecast period are targeted corticosteroid formulations, low-dose and short-duration treatments, a surge in topical and inhaled corticosteroids, combination therapies with bronchodilators, and their expanding application in acute respiratory care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

What Key Drivers Are Influencing The Growth Of The Corticosteroids Market?

The expanding need for cancer therapies is set to drive the growth of the corticosteroid market in the future. Cancer treatment involves a range of approaches, including surgical procedures, chemotherapy, radiation therapy, immunotherapy, and specific targeted interventions, all aimed at eliminating cancerous cells and mitigating symptoms. This growing demand for cancer care stems from multiple factors, such as a higher occurrence of cancer cases, enhanced public awareness and screening efforts, better availability of healthcare, and the provision of supportive care options. Corticosteroids play a crucial role by easing symptoms and improving the tolerance of cancer treatments, which in turn leads to better results for patients and reinforces the rising need for holistic cancer management. As an illustration, in May 2024, the UK’s National Health Service (NHS) indicated that treatment levels reached an unprecedented peak, with more than 1,400 patients starting cancer treatment daily on working days. From April 2023 to March 2024, approximately 340,000 individuals received their initial cancer treatment. Consequently, the increased requirement for cancer treatment propels the expansion of the corticosteroid market.

What Major Segment Divisions Exist Within The Corticosteroids Market?

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

How Are Trends Shaping The Direction Of The Corticosteroids Market?

Leading companies within the corticosteroids market are engaged in developing innovative products, such as rescue medications, to cater to broader customer bases, achieve greater sales, and boost revenue. A rescue medication refers to a type of treatment or drug administered for swift and immediate relief from acute and severe symptoms of a medical condition or a sudden worsening of a chronic ailment. As an illustration, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced the FDA approval for Airsupra (albuterol/budesonide). A distinguishing feature of this product is its designation as the first-in-class pressurized metered-dose inhaler (pMDI), functioning as a fixed-dose combination rescue medication. It incorporates albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) endowed with anti-inflammatory characteristics. This product is indicated for individuals aged 18 years and above and can be employed as needed for addressing or preventing bronchoconstriction. It also assists in decreasing the risk of asthma exacerbations. This combination is accessible in the United States and is under development by AstraZeneca in collaboration with Avillion.

Which Companies Are Leading Innovation In The Corticosteroids Market?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Read the full corticosteroids market report here:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Corticosteroids Market?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Corticosteroids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2832&type=smp

Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company

Drugs For Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the corticosteroids market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Corticosteroids Market show for the 2026–2030 period?

The corticosteroids market size has experienced significant growth in recent years. It is anticipated to expand from $5.93 billion in 2025 to $6.33 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. This historical growth can be attributed to several factors, including the increasing occurrence of asthma and allergies, the established clinical effectiveness of corticosteroids, the widespread adoption of steroid therapies in hospitals, enhanced awareness of inflammatory disease management, and the expansion of pharmaceutical manufacturing capacity.

The corticosteroids market size is projected to undergo significant expansion in the upcoming years. It is expected to reach $8.34 billion by 2030, with a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is primarily driven by an increasing prevalence of autoimmune and respiratory diseases, the development of more secure steroid formulations, a global aging population, enhanced healthcare access in emerging economies, and heightened investment in corticosteroid research. Notable trends for the forecast period include the emergence of targeted corticosteroid formulations, the implementation of low dose and short duration therapies, a rise in the use of topical and inhaled corticosteroids, combination therapies incorporating bronchodilators, and an expanding application in acute respiratory care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

What Drivers Are Shaping The Development Of The Corticosteroids Market?

The corticosteroid market is expected to expand due to the escalating need for cancer treatment. Cancer care involves multiple therapeutic approaches, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments, all aimed at eliminating malignant cells and easing patient discomfort. This escalating demand for cancer interventions is fueled by factors such as a growing prevalence of cancer, enhanced public awareness and screening initiatives, better availability of healthcare, and the provision of supportive services. Corticosteroids play a crucial role by mitigating symptoms and improving the tolerance of various cancer therapies, which in turn leads to better patient results and reinforces the need for extensive cancer support. As an illustration, in May 2024, the National Health Service (NHS), the UK’s healthcare system, announced record-high treatment activity, with more than 1,400 patients starting cancer treatment daily on working days. Moreover, from April 2023 to March 2024, close to 340,000 individuals commenced their initial cancer therapy. Consequently, the increasing requirement for cancer treatment directly propels the expansion of the corticosteroid market.

Which Segments Are Contributing To The Growth Of The Corticosteroids Market?

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

What Upcoming Trends Are Likely To Define The Future Path Of The Corticosteroids Market?

Leading companies in the corticosteroids market are developing innovative products, such as rescue medications, to broaden their customer reach, increase sales, and boost revenue. A rescue medication is a type of treatment or drug designed to provide rapid and immediate relief from acute and severe symptoms of a medical condition or a sudden worsening of a chronic condition. For instance, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced that the FDA approved Airsupra (albuterol/budesonide). A distinguishing characteristic of this product is its classification as the first-in-class pressurized metered-dose inhaler (pMDI), which functions as a fixed-dose combination rescue medication. It contains albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) known for its anti-inflammatory properties. This product is indicated for individuals aged 18 years and older and can be used on an as-needed basis for either treating or preventing bronchoconstriction. It also contributes to lowering the risk of asthma exacerbations. This specific combination is currently available in the United States and is under development by AstraZeneca in collaboration with Avillion.

Who Are The Core Companies Influencing Trends In The Corticosteroids Market?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Which Regions Are Projected To Dominate The Corticosteroids Market In The Coming Years?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Corticosteroids Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2832&type=smp

Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company

Drugs For Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model